Thursday 16 October, 2025
Objectives: To describe the pharmacokinetic properties of rosuvastatin in children ≥6 to < 18 years of age. Methods: A two-compartment population…
Read morePoster: Drug/Disease modeling - Paediatrics
Population pharmacokinetics of bumetanide in term newborn infants with seizures
Thursday 16 October, 2025
Objectives: Experimental data supported the use of bumetanide for the treatment of neonatal seizures due to hypoxic-ischaemic encephalopathy (HIE). The…
Read moreSimultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.
Thursday 16 October, 2025
Objectives: Since glomerular filtration rate (GFR) is responsible for the elimination of a large number of water-soluble drugs [1], the…
Read morePopulation Pharmacokinetic Meta-Analysis of the Antiretroviral Agent Abacavir in HIV-Infected Children
Thursday 16 October, 2025
Objectives: Abacavir (ABC) is one of the recommended nucleoside reverse transcriptase inhibitor (NRTI) against human immunodeficiency virus (HIV); ABC is…
Read more